GlassScriptPhysician profile
Fernando Pablo Secin
NPI 1104425545
$6,621.13
in general payments reported to CMS, 2019-2025
23 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $260 · 2023: $1,635 · 2024: $3,304 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,333 · Travel and Lodging: $1,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,332.85 |
| Travel and Lodging | $1,870.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,414.58 | 2023-2024 | Urolift |
| Boston Scientific Corporation | $1,076.59 | 2021-2024 | Spaceoar Vue System - 10ml |
| Janssen Biotech, INC. | $750.62 | 2023-2025 | Rybrevant, Carvykti, Erleada |
| Olympus America INC. | $530.35 | 2023-2025 | Itind System |
| Procept Biorobotics Corporation | $298.90 | 2024 | Aquabeam System |
| Blue Earth Diagnostics | $257.29 | 2023-2024 | |
| Urogen Pharma, INC. | $245.97 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $243.12 | 2023-2024 | Xiaflex |
| 180 Medical, INC. | $171.00 | 2023 | Cure Catheter |
| Medtronic, INC. | $151.92 | 2023-2024 | Achieve, Ligasure |
| Glaxosmithkline, LLC. | $139.30 | 2023-2024 | Shingrix, Arexvy |
| Convatec INC. | $138.27 | 2022-2024 | |
| Madrigal Pharmaceuticals | $137.20 | 2025 | Rezdiffra |
| Siemens Medical Solutions USA, INC. | $136.41 | 2021 | |
| Janssen Scientific Affairs, LLC | $136.04 | 2025 | Akeega, Erleada |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $126.65 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $121.63 | 2024 | Xarelto |
| Laborie Medical Technologies Corp. | $118.36 | 2025 | Endosheath Technology |
| Tempus Ai, INC | $113.29 | 2024 | |
| Neurelis, INC. | $93.14 | 2024 | Valtoco |
| Davol INC. | $89.85 | 2022 | |
| Endo USA, INC. | $82.23 | 2024-2025 | Xiaflex, Aveed |
| Edap Technomed INC | $48.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Secin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.